These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 31768803

  • 1. Comparison of the effects of valsartan plus activated vitamin D versus valsartan alone in IgA nephropathy with moderate proteinuria.
    Xiaowei L, Bo W, Li L, Peng Z.
    Int Urol Nephrol; 2020 Jan; 52(1):129-136. PubMed ID: 31768803
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the efficacy and safety of TWHF in diabetic nephropathy patients with overt proteinuria and normal eGFR.
    Xiong C, Li L, Bo W, Chen H, XiaoWei L, Hongbao L, Peng Z.
    J Formos Med Assoc; 2020 Mar; 119(3):685-692. PubMed ID: 31801679
    [Abstract] [Full Text] [Related]

  • 3. Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial.
    Liu LJ, Lv JC, Shi SF, Chen YQ, Zhang H, Wang HY.
    Am J Kidney Dis; 2012 Jan; 59(1):67-74. PubMed ID: 22019331
    [Abstract] [Full Text] [Related]

  • 4. Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study.
    Yu MY, Kim YC, Koo HS, Chin HJ.
    PLoS One; 2017 Jan; 12(11):e0188375. PubMed ID: 29155873
    [Abstract] [Full Text] [Related]

  • 5. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G, Liu D, Margetts P, Liu L, Zhao Z, Liu Z, Tang L, Fang Y, Li H, Guo Y, Chen F, Liu F.
    Nephrology (Carlton); 2015 Feb; 20(2):77-84. PubMed ID: 25358874
    [Abstract] [Full Text] [Related]

  • 6. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group.
    Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
    [Abstract] [Full Text] [Related]

  • 7. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C, Tinelli C, Ferrario F, Pani A, De Silvestri A, Scaini P, Del Vecchio L, Alberghini E, Buzzi L, Baragetti I, Pozzi C.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):973-981. PubMed ID: 27129712
    [Abstract] [Full Text] [Related]

  • 8. Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial.
    Jo YI, Na HY, Moon JY, Han SW, Yang DH, Lee SH, Park HC, Choi HY, Lim SD, Kie JH, Lee YK, Shin SK.
    Korean J Intern Med; 2016 Mar 06; 31(2):335-43. PubMed ID: 26874511
    [Abstract] [Full Text] [Related]

  • 9. Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial.
    Ni Z, Zhang Z, Yu Z, Lu F, Mei C, Ding X, Yuan W, Zhang W, Jiang G, Sun M, He L, Deng Y, Pang H, Qian J.
    Ren Fail; 2021 Dec 06; 43(1):1214-1221. PubMed ID: 34396911
    [Abstract] [Full Text] [Related]

  • 10. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec 06; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 11. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.
    Susantitaphong P, Nakwan S, Peerapornratana S, Tiranathanagul K, Katavetin P, Srisawat N, Praditpornsilpa K, Eiam-Ong S.
    BMC Nephrol; 2017 Jan 14; 18(1):19. PubMed ID: 28088187
    [Abstract] [Full Text] [Related]

  • 12. Comparison of glucocorticoids alone and combined with cyclosporine a in patients with IgA nephropathy: a prospective randomized controlled trial.
    Liu H, Xu X, Fang Y, Ji J, Zhang X, Yuan M, Liu C, Ding X.
    Intern Med; 2014 Jan 14; 53(7):675-81. PubMed ID: 24694475
    [Abstract] [Full Text] [Related]

  • 13. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov 14; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 14. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.
    Gao R, Wu W, Wen Y, Li X.
    Int Urol Nephrol; 2017 Jul 14; 49(7):1233-1241. PubMed ID: 28349446
    [Abstract] [Full Text] [Related]

  • 15. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
    Branten AJ, Klasen IS, Wetzels JF.
    Clin Nephrol; 2002 Oct 14; 58(4):267-74. PubMed ID: 12400841
    [Abstract] [Full Text] [Related]

  • 16. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.
    Campbell R, Sangalli F, Perticucci E, Aros C, Viscarra C, Perna A, Remuzzi A, Bertocchi F, Fagiani L, Remuzzi G, Ruggenenti P.
    Kidney Int; 2003 Mar 14; 63(3):1094-103. PubMed ID: 12631093
    [Abstract] [Full Text] [Related]

  • 17. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial.
    Liu LJ, Yang YZ, Shi SF, Bao YF, Yang C, Zhu SN, Sui GL, Chen YQ, Lv JC, Zhang H.
    Am J Kidney Dis; 2019 Jul 14; 74(1):15-22. PubMed ID: 30922594
    [Abstract] [Full Text] [Related]

  • 18. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S, Li JP.
    Trials; 2020 Jan 06; 21(1):31. PubMed ID: 31907076
    [Abstract] [Full Text] [Related]

  • 19. Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.
    Masutani K, Tsuchimoto A, Yamada T, Hirakawa M, Mitsuiki K, Katafuchi R, Hirakata H, Kitazono T, Tsuruya K, West Japan Study Group for Therapy of IgA Nephropathy Investigators.
    Clin Exp Nephrol; 2016 Dec 06; 20(6):896-903. PubMed ID: 26758039
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial.
    Hou FF, Xie D, Wang J, Xu X, Yang X, Ai J, Nie S, Liang M, Wang G, Jia N, MAIN Trial Investigators.
    JAMA Netw Open; 2023 Feb 01; 6(2):e2254054. PubMed ID: 36745456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.